Supreme Court Report

Supreme Court of the United States · Official docket →

Brian Mark Burmaster v. Eli Lilly and Company

Paid petition · United States Court of Appeals for the Sixth Circuit, No. 18-3312 · judgment March 5, 2019

Certiorari denied · October 7, 2019
Pre-decision estimate: 0% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

The primary federal question that I ask is: If a company's manufactured and marketed product, such as Eli Lilly's Zyprexa is cited by the US Government Quack (called a medical doctor?) as the miracle drug to restore an extradited criminal defendant's Sixth Amendment of our sacred US Constitution right to a speedy and public trial by an impartial jury, shouldn't that American pharmaceutical company issue .a cease and desist order immediately to that US Government Quack?

Counsel of record

For petitioner
Brian Mark Burmaster

For respondent
—

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Oct 07 2019
    Petition DENIED.
  2. Jul 17 2019
    DISTRIBUTED for Conference of 10/1/2019.
  3. May 30 2019
    Petition for a writ of certiorari filed. (Response due July 3, 2019)